D-0581-2018 Class III Terminated

Recalled by Osmotica Pharmaceutical Corp — Marietta, GA

FDA drug recall D-0581-2018 was initiated by Osmotica Pharmaceutical Corp on Feb 28, 2018 and is designated Class III. Reason for recall: Subpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet. The recall status is terminated (terminated May 1, 2019). Affected quantity: 19,664 100-bottles.

Recall details

Product Type
Drugs
Report Date
Mar 14, 2018
Initiation Date
Feb 28, 2018
Termination Date
May 1, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
19,664 100-bottles

Product description

Methylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg, 100-count bottle, Rx only, Trigen Laboratories, LLC Bridgewater, NJ 08807. NDC 13811-708-10

Reason for recall

Subpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet.

Distribution pattern

Nationwide in the USA

Code information

Lots: 170231B, 170232A, 170233A, 170234A

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0581-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0581-2018. Report a data issue: hello@regdatalab.com.